BioShares Biotechnology Products ETF (BBP)
|Ex-Dividend Date||Dec 20, 2017|
|Day's Range||52.13 - 53.11|
|Inception Date||Dec 17, 2014|
The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing.
Top 10 Holdings26.94% of assets
|ADC Therapeutics SA||ADCT||2.39%|
|Bny Mellon Cash Reserve Usd||N/A||2.25%|
|Dec 20, 2017||$0.0723||Dec 27, 2017|
|Dec 21, 2015||$0.39725||Dec 29, 2015|
As most corners of the market rallied on the slew of positive news, a few sectors scaled new highs. We have highlighted five ETFs from different sectors that hit all-time highs in the recent trading ses...
After a superb August, September turned gloomy for Wall Street.
After a superb August, September looks gloomy for Wall Street. Still,
Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.